Work

Preclinical Evaluation of CRx-501, a Potent Selective A2A Agonist as a Novel Drug Candidate for the Treatment of Multiple Myeloma

Year: 2008

Type: article

Source: Blood

DOI: 10.1182/blood.v112.11.252.252

Authors: Richard J Rickles, Laura Pierce, Thomas Giordano, William Avery, Melissa Farwell, David Crowe, Winnie F. Tam, Mei Chen, Vikram Kansra, Douglas W. McMillin, Kenneth C Anderson, Constantine Mitsiades, Margaret S. Lee

Institutions: Harvard University, Dana-Farber Cancer Institute

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2574834352

FWCI:

Cites:

Cited by: 3

Related to: 10